Sectoral Asset Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Sectoral Asset Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-57,297	Closed	-$551K	–	113
2023 Q4	$551K	Hold	57,297	–	–	0.24%	74
2023 Q3	$149K	Hold	57,297	–	–	0.03%	119
2023 Q2	$268K	Hold	57,297	–	–	0.04%	115
2023 Q1	$216K	Hold	57,297	–	–	0.04%	111
2022 Q4	$180K	Hold	57,297	–	–	0.03%	114
2022 Q3	$172K	Buy	57,297 +19,099	+50%	+$47.7K	0.03%	104
2022 Q2	$95K	Hold	38,198	–	–	0.02%	112
2022 Q1	$297K	Hold	38,198	–	–	0.05%	103
2021 Q4	$159K	Hold	38,198	–	–	0.02%	108
2021 Q3	$303K	Buy	+38,198	New	+$322K	0.03%	124

Other funds holding FUSN

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sectoral Asset Management's FUSN Position: Q1 2024 in Review

Sectoral Asset Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 57,297 shares — an estimated $551K sold.

Sectoral Asset Management first reported a position in FUSN in Q3 2021 and held it in 10 quarters. The position peaked at $551K in Q4 2023. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

Sectoral Asset Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
Sectoral Asset Management sold 57,297 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $551K.
Sectoral Asset Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2021 and held it in 10 quarters.
Sectoral Asset Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $551K in Q4 2023.
114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.